Ad Scientiam and Kyowa Kirin Join Forces

We are thrilled to announce our partnership with Kyowa Kirin to innovate in digital biomarkers for X-linked hypophosphatemia (XLH), a rare bone disease.

Through this collaboration, we aim to develop revolutionary digital tools to transform the management of XLH .
By combining our expertise with Kyowa Kirin's resources, we will provide clinicians with valuable tools to track disease progression and personalize treatments.